This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Former Customers Of Allscripts MyWay™ Praise Aprima For Fast, Smooth, And Efficient Upgrade

DALLAS, Dec. 21, 2012 /PRNewswire/ -- Aprima Medical Software announced today that its first Aprima Rescue Plan™ customers have successfully upgraded to and 'gone live' with the company's EHR. In only 75 days since Allscripts announced that it has opted not to develop or update the Allscripts MyWay™ product to be in compliance with government incentives and requirements such as Meaningful Use and ICD-10, Aprima has already begun taking 'rescued' medical practices live.


The Aprima Rescue Plan circumvents the need for customers of Allscripts MyWay™ to switch to another Allscripts™ EMR product, which requires a change in systems, plus a potentially arduous data conversion and retraining period, likely creating additional mental, physical, and financial disruption to the practice. These providers are joining the thousands of other providers who have already chosen Aprima over Allscripts™.

One of the first customers to go live, Crystal Community ENT in Florida, had used Allscripts MyWay™ for less than two months when it received notice that the product would not be updated as indicated above. "I did not want to believe what the email notice was telling me – especially the recommendation that we switch to Allscripts Pro, a product we'd already rejected as unsuitable for a small practice. We took a look at some ENT-specific solutions; then we came across Aprima's offer," said Kelly Surrency, the practice's office manager.

She described the upgrade to Aprima's EHR as quick and non-disruptive, with four hours of training more than enough for someone making the switch from Allscripts MyWay™, and no slow-down after the solution went live. "Everything was so familiar! We didn't even have to cut back on patient visits for a few days," Surrency said.

Surrency also noted that, unlike the technical support she previously received for Allscripts MyWay™, there's no wait time from Aprima for clear, easy-to-understand answers from technical support experts. "The other major difference is that Aprima's EHR comes with added functionality we'd requested for Allscripts MyWay™.  For example, with Aprima the Eligibility icons are visible and clear. With Allscripts MyWay™, our staff had to spend a good part of the morning working on benefits. Now we can spend our time doing more productive work," Surrency continued.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs